Artificial Intelligence driven Marketing Communications
Business in the marijuana industry is booming, with market values soaring sky high.
Better get in while the going is good!
Let’s take a look at some of the biggest marijuana companies investors are currently talking about in the market.
Growth in the Cannabis Industry
The marijuana industry has been gaining traction ever since the tides changed in regards to government legalization of this plant.
2018 continued this trend, with three major developments greatly improving the prospects of the cannabis market.
First, California became the first state in the United States to legalize the recreational use of marijuana for adults. Previously, marijuana use was only regulated to medical patients seeking natural, alternative treatment for their ailments. Now, cannabis is legal to enjoy for all who wish to partake.
Next, the whole of Canada joined the ranks of recreational marijuana usage in 2018, as well. Voters country-wide helped approve of this regulation, fostering the beginnings of a new industry for cannabis. Analytic researches expect California and Canada to supply 41% of the global marijuana market by 2022.
The third landmark was the mandate to remove industrial hemp from the list of Schedule I controlled substances in the United States. This monumental change allowed for the production and sale of CBD items, shifting perceptions of what the cannabis species can offer. In turn, analytics expect both CBD and THC product usage to skyrocket by 2022.
Stay up to date to all cannabis-related headlines to keep ahead of the game!
Biggest Marijuana Companies
Let’s take a look at some of the largest marijuana companies in the market today.
This is just a brief overview, feel free to find out more on the market value of each individual companies.
Net worth: $11.5 billion
The head honcho of the cannabis market is currently the Canopy Growth Corp (NYSE: CGC).
Canopy Growth Corp. recently gained its status at the top after Constellation Brands, producer of Corona and Modelo beers, bought 104.5 million shares of Canopy’s stocks. The sale was at 51% premium at the closing on August 14th, 2018.
This company now boasts $4 billion in cash value on its financial reports following the closure of this investment. Investors are expecting that this grand capital will allow for significant expansion in cannabis production. This will lay the foundation for sales in international markets, improve upon their brand, add diversity to their product portfolio, and make acquisitions.
Net worth: $10.3 billion
Tilray only recently went public in July of last year, but already their market value has skyrocketed (NASDAQ: TLRY). They had a market cap of nearly $28 billion by September on an daily basis.
Investors enjoyed high borrowing costs for short sellers under the expectation that Tilray would partner in the beverage or tobacco industry. This pushed the market value higher and higher.
This year, the management team of Tilray is focusing on the expansion of its production capacity. They have listed that Tilray has about 3 million square feet of fertile land ready to meet demands. This is expected to push Tilray into international markets.
Net worth: $5.9 billion
Aurora Cannabis (NYSE: ACB) is expected to take the lead in regards to peak production of annual cannabis output. The company estimates that they will produce 700,000 kilograms of cannabis this year, if not more.
Aurora Cannabis has managed this feat by partnering with other companies in related fields. First, they partnered with organic growers Aurora Sky and Aurora Sun for cannabis production. Then, they teamed up with Aurora Nordic to handle transportation. Lastly, their acquisition with multiple big-name companies like CanniMed Therapeutics and MedReleaf to oversee stores and dispensaries.
Aurora Cannabis is soon becoming a big contender in the marijuana industry, with analytics expecting it to rival Canopy Growth Corp. as the market cap leader.
Net worth: $3.9 billion
GW Pharmaceuticals is the only CBD drug developer to make the ranks as a top contender with its market cap of almost $4 billion (NASDAQ: GWPH).
In June of last year, GW Pharmaceuticals made U.S. history by gaining FDA approval for its leading drug, Epidiolex. This drug is used to treat two rare forms of epilepsy that can arise in children. GW Pharmaceuticals’ cannabidiol-based drug also earned the least rigid scheduling of all from U.S. DEA at a Schedule V level.
Analytics are hopeful that Epidiolex and other products from GW Pharmaceuticals will lead the way for more CBD-scheduling reform at government levels in years soon to come.
Net worth: $2.7 billion
Curaleaf Holdings surprised everyone when it seemingly came out of nowhere late last October. This Massachusetts-based company has seen great earnings in its first moments going public (OTCMKTS: CURLF).
This company currently possess 33 dispensaries, 12 cultivation facilities, and 10 processing sites all over the United States. As interstate transport of cannabis is not yet currently legal under government law, investors are pleased that Curaleaf Holdings has the means to produce in several states without needing transit means.
Net worth: $2.1 billion
Aphria is an Ontario-based company (NYSE: APHA) that is currently the third-largest producer of marijuana. They have an annual output estimated at 255,000 kilograms of organically grown cannabis.
Net worth: $1.7 billion
Green Thumb Industries operates more than a dozen RISE retail marijuana stores and eight growing facilities, earning its spot on our list (OTCMKTS: GTBIF).
Green Thumb Industries seek to expand its market holdings further, with currently over sixty licenses to open more retail locations in states that are heading towards legalization of marijuana. Many are hopeful that this company will grow exponentially as political climates shift in regards to marijuana usage across the country.
There’s no time like the present to get involved in the cannabis industry.
Contact us for more information on how you can get involved with some of the biggest marijuana companies today!